Evaluating neurological complications developed during the COVID-19 pandemic.
Neuropsychiatry and genomics
Examining a range of psychiatric disorders as a result of COVID-19 to better understand and treat these conditions.
Investigating the structural and functional brain changes connected with COVID-19 by analysing MRI data.
Biomarkers and immunology
Identifying immunological or brain-damage related biomarkers linked to neuropsychiatric effects of COVID-19.
Researching how COVID-19 impacts cognitive function in the brain and nervous system.
Comparing different neurovirulent strains of viruses linked with neurological diseases.